Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Taiho Pharmaceutical
Pharma
Taiho ph. 3 win sets up potential oral franchise expansion
The Aztound results have the potential to build upon Taiho’s franchise of combination cancer fighters, including Inqovi.
Donavyn Coffey
Oct 1, 2026 11:38am
US' China deal policy, WCLC, Legend CEO—Fierce Pharma Asia
Sep 18, 2026 10:20am
Legend Biotech, Taiho-Cullinan, WuXi AppTec—Fierce Pharma Asia
Aug 14, 2026 8:52am
Lilly-Innovent, Dizal, bispecific ADC—Fierce Pharma Asia
Jul 10, 2025 5:20pm
Novo, Merck, Hengrui-Elevar—Fierce Pharma Asia
Mar 28, 2025 9:28am
FDA calls out 'concerning' claims on site for Taiho's Lytgobi
Mar 26, 2025 1:21pm
